Displaying 1–25 of 4068 results for

Sort By Relevance Sort By Date
1 2 3 4 5 ...163

Global Blood Therapeutics wins first FDA approval with sickle cell disease med

(News)

The drugmaker says its drug, Oxbryta, can be used in combination with Novartis’s drug, Adakveo, which nabbed FDA approval just last week.

Harvard, MIT, hospitals and industry create facility for next-generation med ...

(News)

They will pool resources to create a new $50 million center for advanced biological innovation and manufacturing in Boston.

CymaBay halts liver drug studies

(News)

CymaBay Therapeutics announced that it is stopping several liver disease studies after liver damage was detected in some patients.

Novartis to buy cholesterol-drug maker for $9.7B

(News)

Novartis has reached a deal to buy cholesterol-drug maker The Medicines Co. for $9.7 billion.

Roche’s new flu drug could trigger drug-resistant strain of influenza

(News)

New research has shown that Roche’s one-and-done influenza pill could cause mutations of the influenza virus that are resistant to the treatment.

Sanofi considers sale, spin-off, joint venture of consumer healthcare unit

(News)

Sanofi is considering a joint venture, spin-off or outright sale of its consumer healthcare unit, according to Reuters sources.

Pharma in review: trending stories 11/22/19

(News)

top stories in pharma manufacturing

Roche extends Spark deadline again...and again

(News)

Roche has extended the deadline for its tender offer for Spark Therapeutics saying U.S. and British anti-trust authorities needed additional time to review the deal.

AstraZeneca gets FDA ok for lymphocytic leukemia drug

(News)

AstraZeneca announced that the U.S. FDA has approved Calquence for adult patients with chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma.

FDA warns Torrent for water system laced with bacteria

(News)

The FDA has slapped India-based Torrent Pharmaceuticals with a warning letter for its water system at a Pennsylvania facility.

Lilly plans $400M manufacturing investment

(News)

Eli Lilly and Co. has announced a manufacturing expansion in Indianapolis that will add 100 new high-skilled jobs to its operations.

Amgen announces plan to axe 172 jobs

(News)

Facing stiffening biosimilar and generics competition, Amgen said it has to cut 172 jobs later this year.

Pfizer nabs FDA approval for Humira biosim

(News)

Abrilada is the fifth Humira biosimilar approved in the U.S. and will join generics from Mylan, Samsung Bioepis and Sandoz when AbbVie's blockbuster has its patent expire in 2023.

Roche buys biotech Promedior in $1.39 billion deal

(News)

The Swiss drugmaker will pay $390 million upfront for the privately held biotechnology company specializing in the development of targeted medicines to treat fibrosis.

Supreme Court rejects Shkreli’s attempt to get out of jail

(News)

The U.S. Supreme Court has turned down an appeal attempt by Martin Shkreli this week.

NHS faces critical drug shortages

(News)

England's National Health Service (NHS) is running short of dozens of lifesaving medicines including treatments for cancer, heart conditions and epilepsy, according to an internal document circulated to doctors.

Novartis gets FDA ok for sickle-cell drug

(News)

Novartis announced it won U.S. FDA approval for its experimental sickle cell disease drug, Adakveo.

Pharma in review: trending stories 11/15/19

(News)

top stories in pharma manufacturing

Shionogi antibiotic gets FDA ok with mortality warning

(News)

Japan's Shionogi announced the U.S. FDA has approved its new antibiotic, Fetroja, for the treatment of complicated urinary tract infections (cUTI).

Teva to resume production of child cancer drug as shortage persists

(News)

Teva Pharmaceuticals announced that it will resume production of childhood cancer drug vincristine after a recent shortage.

Mylan hit with warning letter for valsartan manufacturing

(News)

The FDA sent a Mylan facility in India a warning letting for its manufacturing of APIs related to the widespread recall of blood pressure medications.

Outbreak of a deadly swine fever could trigger global heparin shortage

(News)

Heparin, one of the world’s most critical heart medications, could soon run in short supply due to an outbreak of African swine fever that’s wiped out nearly a quarter of the world’s pigs.

AZ lupus drug hits the mark in late-stage study

(News)

AstraZeneca reported positive results this week from a late-stage lupus study.

Lonza CEO makes sudden, surprise departure

(News)

Lonza investors were reportedly taken aback this week by the surprise announcement that the company’s CEO is planning to step down.

Lupin offloads Japanese subsidiary for $526 million

(News)

The company's subsidiary Nanomi B.V. will divest its entire 99.82% stake to private equity fund Unison, which has experience in the healthcare sector.

Sort By Relevance Sort By Date
1 2 3 4 5 ...163